Students' knowledge of COPD: projects ASCO-1 and ASCO-2 results comparison

被引:0
|
作者
Bontsevich, Roman [1 ]
Filinichenko, Tatyana [1 ]
Gavrilova, Anna [1 ]
Shchurovskaya, Kristina [1 ]
Batisheva, Galina [2 ]
Goncharova, Natalya [2 ]
Ketova, Galina [3 ]
Barysheva, Valeriya [3 ]
Myronenko, Olena [4 ]
Kompaniets, Olga [5 ]
Miliutina, Elena [1 ]
Mikhno, Alina [6 ]
Zhdanova, Zhanna [1 ]
机构
[1] Belgorod State Natl Res Univ, Belgorod, Russia
[2] Voronezh State Med Univ, Voronezh, Russia
[3] South Ural State Med Univ, Chelyabinsk, Russia
[4] Dnipropetrovsk Med Acad, Dnipro, Ukraine
[5] Kuban State Med Univ, Krasnodar, Russia
[6] LLC MAKSBelmed, Belgorod, Russia
关键词
COPD; Education;
D O I
10.1183/13993003.congress-2019.PA1485
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA1485
引用
收藏
页数:2
相关论文
共 50 条
  • [21] The New Equivocal Changes to HER2 FISH Results When Applying the 2013 ASCO/CAP Guidelines
    Long, Thomas H.
    Lawce, Helen
    Durum, Connie
    Moore, Stephen R.
    Olson, Susan B.
    Gatter, Ken
    Troxell, Megan L.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (02) : 253 - 262
  • [22] The New Equivocal: Changes To HER2 FISH Results When Applying the 2013 ASCO/CAP Guidelines
    Long, Thomas
    Lawce, Helen
    Durum, Connie
    Moore, Stephen
    Olson, Susan
    Gatter, Ken
    MODERN PATHOLOGY, 2015, 28 : 54A - 55A
  • [23] Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma
    Kim, Gilhyang
    Chung, Yul Ri
    Kim, Bohyun
    Song, Boram
    Moon, Kyung Chul
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2016, 50 (06) : 436 - 441
  • [24] HER2 testing in Russia: The results of the 10 years of experience. ASCO/CAP recommended score system
    Frank, G.
    Zavalishina, L. E.
    Andreeva, J. J.
    Matsionis, A. E.
    Sazonov, S. V.
    Vinogradov, I. J.
    Petrov, S. V.
    Leenman, E. E.
    Glatko, S. B.
    Gorelik, M. Z.
    VIRCHOWS ARCHIV, 2012, 461 : S241 - S242
  • [25] HER2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines
    McLemore, Lauren E.
    Albarracin, Constance T.
    Gruschkus, Stephen K.
    Bassett, Roland L., Jr.
    Wu, Yun
    Dhamne, Sagar
    Yiml, Isaiah
    Lin, Kevin
    Bedrosian, Isabelle
    Sneigel, Nour
    Chen, Hui
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (01) : 95 - 104
  • [26] HER2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines
    Lauren E. McLemore
    Constance T. Albarracin
    Stephen K. Gruschkus
    Roland L. Bassett
    Yun Wu
    Sagar Dhamne
    Isaiah Yim
    Kevin Lin
    Isabelle Bedrosian
    Nour Sneige
    Hui Chen
    Breast Cancer Research and Treatment, 2021, 187 : 95 - 104
  • [27] COMPARISON OF THE 2007 AND 2013 ASCO/CAP GUIDELINES FOR HER2 ISH TESTING IN INVASIVE BREAST CANCER PATIENTS
    Salido, M.
    Puiggros, A.
    Corominas, J. M.
    Iglesias, M.
    Rodriguez-Rivera, M.
    Melero, C.
    Tusquets Trias Bes, I.
    Albanell, J.
    Serrano, S.
    Servitja Tormo, S.
    Espinet, B.
    ANNALS OF ONCOLOGY, 2014, 25
  • [28] Report from "Meeting after ASCO 2011", 1st-2nd July 2011, Gdansk
    Duchnowska, Renata
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 (06): : 332 - 342
  • [29] HER2 testing in breast cancers: Comparison of Assays and Interpretation Using ASCO-CAP 2013 with 2018 guidelines
    Mclemore, Lauren
    Albarracin, Constance
    Chen, Hui
    Bassett, Roland
    Dhamne, Sagar
    Gruschkus, Stephen
    Yim, Isaiah
    Lin, Kevin
    Wu, Yun
    MODERN PATHOLOGY, 2019, 32
  • [30] HER2 testing in breast cancers: Comparison of Assays and Interpretation Using ASCO-CAP 2013 with 2018 guidelines
    Mclemore, Lauren
    Albarracin, Constance
    Chen, Hui
    Bassett, Roland
    Dhamne, Sagar
    Gruschkus, Stephen
    Yim, Isaiah
    Lin, Kevin
    Wu, Yun
    LABORATORY INVESTIGATION, 2019, 99